First in Human Study

NCT05241665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-06-18

No results posted yet for this study

Summary

Investigational, prospective, multi-site, first in human, feasibility evaluation

Conditions

Interventions

DEVICE

SpectraWAVE Imaging System

Coronary imaging

Sponsors & Collaborators

  • SpectraWAVE, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-28
Primary Completion
2023-04-21
Completion
2023-05-21
FDA Device
Yes

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241665 on ClinicalTrials.gov